AMERISAFE Financial Statements (AMSF) |
||||||||||
AMERISAFEsmart-lab.ru | % | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
---|---|---|---|---|---|---|---|---|---|---|
Report date | 27.10.2023 | 31.12.2023 | 26.04.2024 | 30.07.2024 | 25.10.2024 | 25.10.2024 | ||||
Currency | USD | USD | USD | USD | USD | USD | ||||
Financial report URL | ||||||||||
Revenue, bln rub | ? | 72.7 | 80.1 | 80.5 | 75.8 | 78.7 | 315.1 | |||
Operating Income, bln rub | 12.3 | 23.9 | 20.7 | 13.7 | 17.8 | 76.2 | ||||
EBITDA, bln rub | ? | 0.000 | 24.3 | 0.000 | 0.000 | 0.000 | 24.3 | |||
Net profit, bln rub | ? | 9.96 | 19.2 | 16.9 | 11.0 | 14.3 | 61.4 | |||
OCF, bln rub | ? | 5.13 | 3.97 | 7.51 | -2.59 | 8.45 | 17.3 | |||
CAPEX, bln rub | ? | 0.490 | 0.026 | 0.746 | 0.056 | 0.024 | 0.852 | |||
FCF, bln rub | ? | 4.64 | 3.94 | 6.76 | -2.65 | 8.43 | 16.5 | |||
Dividend payout, bln rub | 6.57 | 73.6 | 7.08 | 7.10 | 7.09 | 94.9 | ||||
Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
Dividend payout ratio, % | 66.0% | 383.8% | 41.8% | 64.6% | 49.5% | 154.5% | ||||
OPEX, bln rub | 43.9 | 19.0 | 18.7 | 20.4 | 78.7 | 136.8 | ||||
Cost of production, bln rub | 16.4 | 0.000 | 12.8 | 14.5 | 15.6 | 42.9 | ||||
R&D, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
Interest expenses, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
Assets, bln rub | 1 297 | 1 229 | 1 116 | 1 110 | 1 255 | 1 255 | ||||
Net Assets, bln rub | ? | 335.9 | 292.5 | 301.1 | 301.0 | 314.4 | 314.4 | |||
Debt, bln rub | 0.000 | 0.267 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
Cash, bln rub | 59.2 | 355.7 | 427.6 | 166.3 | 378.8 | 378.8 | ||||
Net debt, bln rub | -59.2 | -355.5 | -427.6 | -166.3 | -378.8 | -378.8 | ||||
Ordinary share price, rub | 50.1 | 46.8 | 50.2 | 43.9 | 48.3 | 51.0 | ||||
Number of ordinary shares, mln | 19.2 | 19.2 | 19.1 | 19.1 | 19.0 | 19.0 | ||||
Market cap, bln rub | 960 | 896 | 959 | 838 | 920 | 972 | ||||
EV, bln rub | ? | 900 | 541 | 532 | 671 | 542 | 593 | |||
Book value, bln rub | 317 | -542 | 282 | 281 | 314 | 314 | ||||
EPS, rub | ? | 0.52 | 1.00 | 0.89 | 0.58 | 0.75 | 3.23 | |||
FCF/share, rub | 0.24 | 0.21 | 0.35 | -0.14 | 0.44 | 0.87 | ||||
BV/share, rub | 16.5 | -28.3 | 14.8 | 14.8 | 16.5 | 16.5 | ||||
EBITDA margin, % | ? | 0.00% | 30.3% | 0.00% | 0.00% | 0.00% | 7.71% | |||
Net margin, % | ? | 13.7% | 23.9% | 21.0% | 14.5% | 18.2% | 19.5% | |||
FCF yield, % | ? | 1.80% | 3.27% | 2.36% | 1.52% | 1.79% | 1.70% | |||
ROE, % | ? | 19.0% | 21.2% | 20.5% | 19.0% | 19.5% | 19.5% | |||
ROA, % | ? | 4.91% | 5.05% | 5.53% | 5.14% | 4.90% | 4.90% | |||
P/E | ? | 15.1 | 14.4 | 15.6 | 14.7 | 15.0 | 15.8 | |||
P/FCF | 55.6 | 30.6 | 42.4 | 66.0 | 55.9 | 59.0 | ||||
P/S | ? | 3.13 | 2.92 | 3.11 | 2.71 | 2.92 | 3.08 | |||
P/BV | ? | 3.03 | -1.65 | 3.40 | 2.98 | 2.93 | 3.09 | |||
EV/EBITDA | ? | 13.4 | 8.27 | 12.1 | 27.6 | 22.3 | 24.4 | |||
Debt/EBITDA | -0.88 | -5.44 | -9.75 | -6.84 | -15.6 | -15.6 | ||||
R&D/CAPEX, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
CAPEX/Revenue, % | 0.67% | 0.03% | 0.93% | 0.07% | 0.03% | 0.27% | ||||
AMERISAFE shareholders |